Date of Investment

Auregen BioTherapeutics

Headquartered in Switzerland with facilities in Boston, Auregen is translating pioneering 3D bioprinting technology for innovative treatments for patients with rare disorders.

By putting patients first, Auregen aspires to build a biotherapeutics platform focused on regenerative medicine that will change people’s lives.